Less Ads, More Data, More Tools Register for FREE

Pin to quick picksThruvision Grp Regulatory News (THRU)

Share Price Information for Thruvision Grp (THRU)

Share Price is delayed by 15 minutes
Get Live Data
0.675    0.00 (0.00%)
Bid:
0.65
Ask:
0.70
Spread: 0.05 (7.692%)
Market Cap: £3.03m
THRU Live PriceLast checked at - London Stock Exchange

Intraday Thruvision Grp Share Chart

Result of AGM

19 Sep 2024 11:50

RNS Number : 9058E
Thruvision Group PLC
19 September 2024
 

19 September 2024

Thruvision Group plc

 

Result of Annual General Meeting

 

Thruvision Group plc (AIM: THRU), the leading provider of walk-through security technology, announces that following the Annual General Meeting ("AGM") held earlier today, all resolutions were duly passed by the requisite majority. The number of proxies received in respect of each resolution were as follows:

 

Resolution

Total votes for

%

Total votes against

%

Total votes cast

Votes withheld

1.

Receipt of directors and auditors report

130,323,945

99.99

10,040

0.01

130,333,985

18,005

2.

Approval of remuneration report

118,210,281

90.70

12,122,285

9.30

130,332,566

19,424

3.

Re-election of Tom Black

130,303,637

99.98

25,498

0.02

130,329,135

22,855

4.

Re-election of Colin Evans

128,800,637

98.82

1,533,348

1.18

130,333,985

18,005

5.

Re-election of Victoria Balchin

130,313,637

99.98

20,348

0.02

130,333,985

18,005

6.

Re-election of Richard Amos

130,313,637

99.98

20,348

0.02

130,333,985

18,005

7.

Re-election of Katrina Nurse

130,313,637

99.98

20,348

0.02

130,333,985

18,005

8.

Re-appointment of Auditors

130,179,611

99.88

154,374

0.12

130,333,985

18,005

9.

Authority for Directors to set Auditors remuneration

130,316,399

99.99

17,586

0.01

130,333,985

18,005

10. 

Authority for Directors to allot equity securities

130,313,637

99.99

15,498

0.01

130,329,135

22,855

11. 

Authority for Directors to allot equity securities for cash on a non-premptive basis

130,167,142

99.87

163,498

0.13

130,330,640

21,350

12. 

Authority for Directors to allot equity securities for cash in respect of an acquisition or other capital project.

130,167,142

99.87

171,998

0.13

130,339,140

12,850

13. 

Authority for the Company to make market purchases of its own Ordinary Shares

130,170,487

99.87

171,998

0.13

130,342,485

9,505

 

Notes

1. Any proxy appointments which gave discretion to the Chairman have been included in the 'Total votes for' total.

2. A 'Vote Withheld' is not a valid vote in law and was not counted in the calculation of the proportion of the votes 'for' or 'Against' a resolution. 

3. All percentages have been rounded to two decimal places.

 

 

For further information please contact:

 

Thruvision Group plc

Colin Evans, Chief Executive

Victoria Balchin, Chief Financial Officer

+44 (0)1235 425400

Investec Investment Banking (NOMAD & Broker)

James Rudd / Patrick Robb / Sebastian Lawrence

+44 (0)20 7597 5970

 

About Thruvision (www.thruvision.com)

Thruvision is the leading developer, manufacturer and supplier of walk-through security technology. Its technology is deployed in more than 20 countries around the world by government and commercial organisations in a wide range of security situations, where large numbers of people need to be screened quickly, safely and efficiently. Thruvision's patented technology is uniquely capable of detecting concealed objects in real time using an advanced AI-based detection algorithm. The Group has offices and manufacturing capability in the UK and US.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
RAGSFUFSUELSELU
Date   Source Headline
10th Jul 20267:00 amRNS-RUK Government NPSA testing update
26th Jun 20267:00 amRNSResults for the year ended 31 March 2026
23rd Jun 202610:58 amRNSNotice of Results
19th Jun 20267:00 amRNS-RRetail Distribution orders received Sensormatic
14th May 20267:00 amRNS-RNew Strategic Partnerships
7th May 202611:45 amRNSBlocklisting cancellation and interim review
7th May 202611:45 amRNSBlocklisting cancellation and interim review
8th Apr 20267:00 amRNSFY26 Trading Update
13th Mar 20267:00 amRNSUS Aviation Contract Award
13th Mar 20267:00 amRNSUS Aviation Contract Award
19th Feb 20267:00 amRNSHolding(s) in Company
19th Feb 20267:00 amRNSContract awards into UK custodial facilities
12th Feb 20267:00 amRNS-RFirst UK “Screening as a Service” Sales
22nd Jan 20267:00 amRNS-RUK Retail Distribution Contract Award
20th Jan 20267:00 amRNSSouth-East Asian Mass Transit Contract Award
12th Jan 20267:00 amRNSHolding(s) in Company
5th Jan 202611:27 amRNSAward of Share Options
19th Dec 20251:07 pmRNS-RUS Retail Distribution Contract Award
19th Dec 20251:07 pmRNS-RUS Retail Distribution Contract Award
16th Dec 20257:00 amRNSHolding(s) in Company
11th Dec 20257:00 amRNSHolding(s) in Company
8th Dec 20257:00 amRNS-RImminent contract award
4th Dec 20257:00 amRNSHolding(s) in Company
28th Nov 20253:45 pmRNSHolding(s) in Company
26th Nov 20257:00 amRNSHolding(s) in Company
25th Nov 20257:00 amRNSInterim Results and Trading Update
6th Nov 20254:30 pmRNSBlock listing Interim Review
6th Nov 20254:30 pmRNSBlock listing Interim Review
23rd Oct 202510:53 amRNSResult of AGM
23rd Oct 20257:00 amRNSAGM Statement and Trading Update
6th Oct 20251:49 pmRNS-RNPSA Testing Update
30th Sep 202512:33 pmRNSHolding(s) in Company
29th Sep 202512:04 pmRNSHolding(s) in Company
29th Sep 202511:26 amRNSDirector/PDMR Shareholding
25th Sep 20257:00 amRNSNotice of AGM
19th Sep 20257:00 amRNSFinal Results
15th Sep 202512:40 pmRNSHolding(s) in Company
9th Sep 20257:00 amRNS-RAdditions to Value-Added Reseller Network
1st Aug 20259:46 amRNSHolding(s) in Company
1st Aug 20257:00 amRNSHolding(s) in Company
31st Jul 20255:00 pmRNSTotal Voting Rights
31st Jul 20252:37 pmRNSHolding(s) in Company
31st Jul 20252:01 pmRNSHolding(s) in Company
31st Jul 202510:32 amRNSHolding(s) in Company
31st Jul 20257:00 amRNSHolding(s) in Company
29th Jul 20251:54 pmRNSHolding(s) in Company
28th Jul 202510:50 amRNSResult of GM and completion of Capital Raising
28th Jul 20257:00 amRNSChange of Adviser
8th Jul 20257:00 amRNSResult of Retail Offer & Notice of General Meeting
4th Jul 20257:05 amRNSWRAP Retail Offer

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.